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The aim of the present study was to evaluate the anxiolytic effects of hydroalcoholic extract
(HE) of Nepeta persica Boiss. (Lamiaceae) on the elevated plus-maze (EPM) model of anxiety.
The extract of arial parts of the plant was administered intraperitoneally to male NMRI mice,
at various doses, 30min before behavioural evaluation. The HE extract of N. persica at the dose
of 50mgkg
 1 significantly increased the percentage of time spent and percentage of arm entries
in the open arms of the EPM. This dose of plant extract affected neither animal’s locomotor
activity nor ketamine-induced sleeping time. The 50mgkg
 1 dose of the plant extract seemed to
be the optimal dose in producing the anxiolytic effects, lower or higher doses of the plant
produce either sedative or stimulant effects. At 100mgkg
 1, the plant extract increased the
locomotor activity. These results suggested that the extract of N. persica at dose of 50mgkg
 1
possess anxiolytic effect with less sedative and hypnotic effects than that of diazepam and
causes a non-specific stimulation at 100mgkg
 1.
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Introduction
Anxiety disorders are the most common mental illness in
the world and became a very important area of research
interest in psychopharmacology. Benzodiazepines are
among the first line of drugs that have been extensively
used for the last 45 years to treat several forms of anxiety
(1). Although benzodiazepines have well-known benefits,
their side effects are prominent, including sedation,
muscle relaxation, anterograde amnesia and physical
dependence (2). It is because of these adverse effects
that many pharmaceutical companies are conducting
studies to find an alternative medicine or plant-derived
medications with more specific anxiolytic effects. Some
of these plants that have been tested and shown to
‘calm down’, tranquilize and raise mood include
Valeriana officinalis (3–5), Matricaria recutita (6),
Passiflora caerulea (7), Salvia guaranitica (8), Tilia
tomentosa (9), Tilia europaea (10), Stachys lavandulifolia
(11), Echium amoenum (12) and Salvia reuterana (13).
Nepeta (Lamiaceae) is a genus of perennial or annual herbs
found in Asia, Europe and North Africa. About 250
species of Nepeta are reported (14) of which, 67 species are
available in Iran (15). Nepeta species are widely used in
folk medicine because of their antispasmodic, expectorant,
diurectic, antiseptic, antitussive, antiasthmatic and febri-
fuge activities (16–18). Nepeta cataria (Catnip) is the most
famous Nepeta species, which has a long history of use as a
tea in Europe before real tea was imported from the orient.
The flowering tops of the plant have also been used as
sedative drug (19). Many reports on Nepeta species show
that the main constituents of the oil are diastereomeric
nepetalactones. Nepetalactones are reported to have
considerable sedative activity (20). These compounds are
also responsible for their feline attractant or insect
repellant properties (21). Nepeta persica which is native
to Iran, has been proven to have similar compounds (22).
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properly cited.Despite the use of N. persica as an anxiolytic, there is
no pharmacological data to support such effects. The aim
of the present study was to investigate the anxiolytic
effect of ethanolic extract of N. persica in the elevated
plus-maze (EPM), a behavioral test for anxiolytic
drugs (23). In addition to EPM, we also analyzed the
effects of N. persica on spontaneous activity and its
interaction with a CNS depressant.
Methods
Preparation of the Plant Material
Arial parts of N. persica were collected from hights of
Kolahghazi (1850m above sea level) in Isfahan province
in Iran. For preparation of hydroalcoholic extract,
air-dried and powdered sample of the plant (120g) was
macerated with 360ml of ethanol and water (8:2) for
48h. The extract was then shaken, filtered and evapo-
rated in a rotating evaporator under reduced pressure to
give a residue (20g). The residue was dissolved in normal
saline for final suitable concentrations.
Mice
Male NMRI mice (Pasteur, Tehran) weighing 25–30g were
housed in cage (six in each cage) and kept in a room with
controlled temperature (22–25 C). Mice were maintained
on a 12:12 light-dark cycle and had access to food and
water ad libitum. Tests were performed only after the
mice had acclimated to the above environment for at least
7 days. All experiments were carried out between 09:00 and
13:00h. Each mouse received a single intraperitoneal (ip)
injection of drugs (diazepam, 1.5mgkg
 1; ketamine,
100mgkg
 1), plant extract (different doses) or vehicle
(normal saline) and was tested once in the EPM. Minimum
of six mice were used for each treatment group.
All procedures were approved by the Ethical Committee
of the Isfahan University of Medical Sciences, and
conducted in accordance with the internationally accepted
principles for laboratory animal use and care. Drugs
Diazepam and ketamine were purchased from Sobhan
Pharmaceutical Co. Iran, and Parke-Davis, France.
Elevated Plus-Maze
The EPM test is described in details elsewhere (24,25).
Briefly, the apparatus comprised two open arms
(35 5cm) and two closed arms (30 5 15cm) that
extended from a common central platform (5 5cm).
The floor and the walls of each arm were wooden and
painted black. The entire maze was elevated to a height
of 60cm above floor level as validated and described by
Lister (23). Testing was conducted in a quiet room that
was illuminated only by a dim light.
Mice were given a single ip dose of the plant extract
30min before their placement on the EPM. To begin a
test session, mice were placed on the open arm facing the
center of the maze. An entry into an arm was defined as
the animal placing all four paws over the line marking
that area. The number of entries and the time spent in
the open and closed arms were recorded during a 5-min
test period. The percentage of open arm entries
(100 open/total entries) was calculated for each
animal. Between each trial, the maze was wiped clean
with a damp sponge and dried with paper towels.
Locomotor Activity
The actions of plant extract on spontaneous locomotor
activity were measured automatically by breaking of
infrared beams as described in details elsewhere (26). The
units of the activity counts were arbitrary and based on
the beam breaks by movement of mice. Each mouse
was injected with the plant extract (25–400mgkg
 1),
diazepam (1.5mgkg
 1) or vehicle (normal saline) and
then, after 30-min interval, placed in a novel cage in the
infrared apparatus. The locomotor activity was measured
at 5-min interval for the next 15min. Six mice were used
for each treatment group. The treatments were random-
ized throughout the day, between 08:00 and 13:00h,
to control for diurnal variations in activity.
Ketamine-Induced Sleeping Time
The effect of plant extracts on ketamine-induced sleeping
time was measured as described by Mimura et al. (27).
After 30min pre-treatment with the plant extracts
(25–400mgkg
 1), diazepam (1.5mgkg
 1) or vehicle,
mice were injected with ketamine (100mgkg
 1, ip).
In the case of the control, mice were pre-treated with
saline and after 30min received only ketamine. The
interval between the administrations of ketamine until
the loss of the righting reflex was recorded as onset of
sleep, while the time from the loss to regaining of the
righting reflex as the duration of sleep (28). Diazepam
(1.5mgkg
 1) was used as standard drug. Minimum of six
mice were used for each treatment group.
Statistics
Statistical analysis was performed using one-way analysis
of variance (ANOVA) with post hoc Tukey test. P50.05
was considered significant. All data are expressed as
mean SEM.
Results
Elevated Plus-Maze Studies
In EPM, the behavior confirmed the anxiolytic activity
of diazepam as reported previously (29). In order to
182 Anxiolytic effect of Nepeta persica Boiss. in micedetermine the effective dose on the EPM, various doses
(25–400mgkg
 1) of plant extracts were tested. The
hydroalcoholic extract of N. persica only at a dose of
50mgkg
 1 significantly increased the percentage of time
spent [F(2,36)¼17.99, 99%] and percentage of entries in
the open arms [F(2,36)¼14.01, 64%, P50.05, Figs 1A
and 2A]. Other doses of the plant extract had no
significant effects on the measured EPM parameters
(Figs 1 and 2). Diazepam at 1.5mgkg
 1 significantly
increased the total arm entry (Fig. 3), while total entry
was not significantly altered by the plant extract at doses
of 50 and 100mgkg
 1 (Fig. 3).
Analyses of Locomotor Activity
Two doses (50 and 100mgkg
 1) of plant extract were
tested for their effects on locomotor activity. Figure 4A
shows the locomotor activity counts measured at three
time intervals of 5, 10 and 15min. The dose of
100mgkg
 1 of the plant extract, significantly increased
the locomotor activity at time intervals of 5min
[F(1,18)¼64.88] and 10min [F(2,27)¼29.29, P50.05,
Fig. 4A]. The increase in locomotor activity was not
observed with the dose of the plant extract at 50mgkg
 1
(Fig. 4A). Diazepam on the other hand significantly
decreased the locomotor activity at three times intervals.
As shown in Fig. 4B, the total locomotor activity count
measured in 15min of the test was significantly decreased
in mice pre-treated with diazepam [F(1,18)¼30, P50.05],
however, this effect was not significantly changed with
the plant extract at 50mgkg
 1. The plant extract at
100mgkg
 1, however, significantly increased the activity
counts (Fig. 4B).
Time to Loss of Righting Reflex
In saline treated control mice the righting reflex was lost
after 107 11s of ketamin injection. Injection of plant
extract (30min prior to ketamin) at doses of 50 and
100mgkg
 1 did not significantly change the latency to
sleep (Fig. 5A). In mice pretreated by saline control,
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Figure 1. Diazepam, saline and different doses of N. persica extract on
(A) the percentage of time spent in the open arms and on (B) time spent
in the open arms during a 5min test in mice. Various doses of the plant,
diazepam or vehicle, were injected 30min prior to test. Data are
presented as mean SEM for each group of nine mice. *P50.05
compared with vehicle-treated control.
þP50.05 compared with
diazepam-treated group.
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Figure 2. Diazepam, saline and different doses of N. persica extract on
(A) the percentage of entries in the open arms and on (B) entries in the
open arms during a 5min test in mice. Various doses of the plant,
diazepam or vehicle, were injected 30min prior to test. Data are
presented as mean values SEM for each group of nine mice. *P50.05
compared with vehicle-treated control.
þP50.05 compared with
diazepam-treated group.
eCAM 2008;5(2) 183total sleep time was 1170 259s (Fig. 5B). Treating the
mice with diazepam significantly increased the total
sleeping time by 148% [F(1,16)¼10.82, P50.05, while
the plant extract at dose of 50 and 100mg/kg did not
significantly alter this parameter (Fig. 5B).
Discussion
In the present study, we used the EPM model of anxiety
to evaluate the anxiolytic effects of the hydroalcoholic
extract of N. persica. This is a model which uses the
natural fear of rodents to avoid open and elevated places.
The ratio of open:closed area entries reflects a specific
effect on anxiety, provided there is no concomitant
change in the total number of entries (openþclosed),
however, this is not totally true for diazepam which
increases preference for the open areas i.e. total
entries (30). As expected, diazepam produced significant
increases in open arm time and in number of entries into
the open arms. Diazepam also increased the total number
of entries. These data are in agreement with the results of
other studies, where diazepam and other benzodiazepines
have been shown to produce robust anxiolytic effects in
a variety of anxiolytic screening procedures, including
conflict model (31), EPM procedures (32) and other non-
punishment procedures (33).
The behavioral alterations induced by the N. persica
plant extract in the EPM provided anxiolytic effect
at 50mgkg
 1. However, unlike many other plant extracts
(11–13) where anxiolytic effects was accompanied by
sedative action, increase in the dose of N. persica exerted
stimulation rather than sedation. An inverted U shaped
dose-response curve that was seen with N. persica extract,
was also evident in other studies (34). Plant extract at doses
higher than 400mgkg
 1 caused stretching postures indica-
tive of colic pain in the mice.
The results also show that the extract of N. persica at
both 50 and 100mgkg
 1 did not statistically change the
latency to sleep and sleeping time induced by ketamin.
This effect further confirms the absence of sedative
properties of the extract. Previous studies show that
Nepeta persica contains a group of lactones called
nepetalactones (19) which is thought to be responsible
for the sedative action of the plant (20). Nepeta cataria
which is used as sedative in European folk medicine also
contains monoterpenoids, a group which is thought to be
composed of anxiolytic components such as linalool
(19,35). The volatile oil of N. persica has been shown
to contain 2.8% and 30.5% linalool and nepetalac-
tones (22). Although it seems that linalool has sedative
effect but the main observed effects in this case could be
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Figure 3. Diazepam, saline and different doses of N. persica extract on
total number of entries in open and close arms. Various doses of
the plant, diazepam or vehicle, were injected 30min prior to test.
Data are presented as mean SEM for each group of nine mice.
*P50.05 compared with vehicle-treated control.
þP50.05 compared
with diazepam-treated group.
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Figure 4. Diazepam, saline and different doses of N. persica extract on
(A) spontaneous locomotor activity during three 5-min intervals and on
(B) spontaneous locomotor activity during total 15min. The locomotor
activity counts (mean SEM) were measured over a 15-min period,
beginning 30min after the administration of saline, diazepam or
different doses of N. persica. Data are presented as mean SEM for
each group of six mice. *P50.05 compared with vehicle-treated control.
þP50.05 compared with diazepam-treated group.
184 Anxiolytic effect of Nepeta persica Boiss. in micedue to the presence of nepetalactones. Alkaloids are the
most important secondary metabolites in many plants
that are held responsible for their sedative and anxiolytic
actions (36). However, as the major constituent of the
N. persica is the observed anxiolytic action is more likely
to be due to nepetalactones rather than alkaloids.
Further investigation is required to fractionate the extract
of the plant and study each fraction separately for their
anxiolytic effects. Isolation of active constituent(s) of the
plant extract could pave the way for the standardization
of biologically active compound as in the case of Turnera
aphrodisiac Ward (37).
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